CMOPF

COSMO PHARMA NV ORD by Cosmo Pharmaceuticals NV (CMOPF)

About COSMO PHARMA NV ORD by Cosmo Pharmaceuticals NV (CMOPF)

Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.

Details

Daily high

$132.38

Daily low

$123.24

Price at open

$125.72

52 Week High

$135.95

52 Week Low

$55.00

Market cap

1.9B

Dividend yield

1.93%

Volume

753

Avg. volume

1,703

P/E ratio

32.49

COSMO PHARMA NV ORD by Cosmo Pharmaceuticals NV News